Broad protection against influenza infection by vectored immunoprophylaxis in mice.
about
Gene therapy: progress and predictionsEmerging Vaccine TechnologiesEngineering humoral immunity as prophylaxis or therapyState-of-the-art human gene therapy: part I. Gene delivery technologiesStudies of retroviral infection in humanized micePassive immunization against HIV/AIDS by antibody gene transfer.A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Universal influenza vaccines: Shifting to better vaccines.Viral vector-based influenza vaccines.Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection.Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.The potential of adeno-associated viral vectors for gene delivery to muscle tissue.Virus-vectored influenza virus vaccines.Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in miceAdeno-associated virus: fit to serveAdeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus.State-of-the-art human gene therapy: part II. Gene therapy strategies and clinical applications.Broadly neutralizing antibodies abrogate established hepatitis C virus infectionAntigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression.Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of CancerAAV Vectors Vaccines Against Infectious Diseases.Broadly neutralizing antibodies and the promise of universal vaccines: where are we now?Inflammasomes in antiviral immunity: clues for influenza vaccine development.In situ production of therapeutic monoclonal antibodies.State of play and clinical prospects of antibody gene transfer.A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination.Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies?Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.Influenza: viral vector delivers protective antibodies.In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections.DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections.Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice.Neutralizing Antibodies Induced by Gene-Based Hydrodynamic Injection Have a Therapeutic Effect in Lethal Influenza Infection.Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza.How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle
P2860
Q26772109-3E099D76-380D-40EA-880C-68CE93318EB0Q26783764-346995A5-545E-4FC6-9F00-5E6AB02931F4Q26800101-8AEB5537-B8E6-4F9D-9571-044A59C55739Q26825575-925C3DA1-D032-4C48-9C27-D68A6206B8D4Q26849806-773FC163-A7B0-4E06-9258-98EF4246C3C1Q30358434-2B0F317E-F278-48F7-90A5-537AF1FD3B72Q30370147-79FBA8E3-0628-4B3B-9E3D-724B86AF4957Q30386388-F237808E-B3A7-40E0-BA03-EE12B645351AQ30390938-5FFC5660-A86F-43B0-9C33-E8CD56675821Q30393562-BCFADD8D-F206-4B52-ACD9-7B5357885A42Q30394097-C7EEF439-0888-4C4B-BAB4-9A407AB9E81BQ33902499-77F74D47-54BF-4AA2-8E4F-92B711F4AAEBQ34102268-DCF4832E-1662-42B3-9B4C-59F2BC32D96AQ34119885-F3B33D21-40B6-4955-B06C-A05C24BB64C9Q34332817-FDB676C4-309B-45F0-BF8B-8CC89BC80DE3Q34592968-6F1569C6-7C0C-43E4-918A-5718BB6DBA1BQ34664690-0EE84A80-62A1-486B-80C0-8B0972A4E448Q35032263-158DA087-419F-4270-81CE-55468EB0C334Q35069151-9BD997CF-9BAA-47B8-B859-AEA70FF74F29Q35418068-89E9ED42-2446-4257-B4EF-997B71F1999FQ35898318-C719A706-352F-496C-8CE2-62FE20D3302FQ35914292-0A0C8BC0-9048-4316-B819-BC6FF1BA6B9EQ35949356-A1179DAF-2D62-44D8-A83C-E265FD77677BQ37498000-C3EE14F9-F5AA-4C05-B885-1D5C81DBD89AQ38171571-268681D6-932D-4A14-BD9B-3573FDD2591CQ38178692-3DA9F9BB-8EF6-4C2D-8553-910B61ACBB1DQ38314210-05C725E8-7C2D-472E-97C3-7497D9480B1CQ38737706-BA91F785-77F5-409E-9D72-742965D63103Q38843133-BFCE49AF-121B-4891-A4DF-EE50C849F9DDQ40040079-9A318C67-6E81-4D03-AF0B-BCB739DA5D00Q40065071-D91FEBA1-5483-4C76-B5EF-400D9A280CF8Q40729252-D0A66BE5-8207-42B8-8D01-EEC3D7D579D7Q42282886-BBE17FA8-FBB9-4DFF-BEC2-0202F3E9C361Q42373127-CB63678A-336E-4932-B6E2-A224AB693562Q47125106-9DD0A0AF-5F45-493F-A78B-63086529315CQ47549288-EF5FDA82-D511-4B22-B597-B895ABFCF726Q48507448-1BC24A43-8A73-434B-818F-94DF83F64E9CQ55317717-97519A31-875B-408A-802D-D34BC3B0826BQ55318229-6084AE66-0CE8-4D07-B8E1-A14A08611140Q56889545-B7D92C8D-55BB-4F89-89ED-BACF485508BA
P2860
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@ast
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@en
type
label
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@ast
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@en
prefLabel
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@ast
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@en
P2860
P50
P356
P1433
P1476
Broad protection against influenza infection by vectored immunoprophylaxis in mice.
@en
P2093
Christin M Hong
David Baltimore
P2860
P2888
P304
P356
10.1038/NBT.2618
P577
2013-06-02T00:00:00Z